Superdrug

73 days ago

Skinbiotherapeutics: not doing itself any favours over the Superdrug release

I am not saying that Stuart Ashman has goofed operationally. But in terms of being transparent with investors he really is clueless and I say that in a spirit of Christian compassion.

86 days ago

I realise Stuart Ashman cares only about his bloated pay but what about the Superdrug launch?

The pretext for the June 16 placing by Skinbiotherapeutics (SBTX) conducted before the company ‘fessed that it was going to miss June 30 revenue forecasts by a country mile, was that cash was needed for a new product launch with Superdrug.

121 days ago

Skinbiotherapeutics: A reader contacts AIM Regulation and the FCA re inaccurate forecasts

I do not disagree with a word in this email. I have also made my views clear to the regulators. It is abundantly clear that forecasts out there are wrong and that the company and ts house broker knows all about it and is happy to see a false market continue. The reader writes:

136 days ago

Doing Kevin Keegan’s job for him: Forecasting Skins sales prize contest and my forecasts

I am not sure what the prize will be but there will be one. Stuart Ashman has said that the research from analyst “Kevin” Keegan at house broker Singer contain errors and we all know the sales numbers are just plain wrong. I will explain my forecasts for the years ending June 30 2025 and 2026 below. The contest is to give your 2026 forecast and as a tie breaker 2025.

149 days ago

Just when you thought the Cavendish coverage of Skins was utterly crap… Singers makes you look back to a golden past! Its numbers are all wrong!

The Singer’s initiation note on its corporate client Skinbotherapeutics(SBTX) is a curious piece of fish. For staters Singer’s makes it clear that it will not, under any circumstances, be made available to private investors it is for II’s and City HNWIs only. This is pointless.

171 days ago

Two video clips – can anyone explain why Stuart Ashman of Skinbiotherapeutics is not a LIAR?

Today Skinbiotherapeutics (SBTX) has announced that Superdrug is to sell its acne and psoriasis products. That is the good news. But to fund the rollout it has diluted us all by another 10% with a placing. On 16 April CEO Stuart Ashman recorded an Investor Meet video. Here are two clips. Please can anyone explain why he is not now exposed as a 100% lying scumbag?